New pill tested for tough cancers like mesothelioma
NCT ID NCT04857372
Summary
This early-stage study is testing a new oral medication called IAG933 in adults with advanced cancers, including mesothelioma, that have specific genetic changes. The main goals are to find a safe dose and see how well the body handles the drug. Researchers will also look for early signs that the drug might help control tumor growth in patients who have run out of standard treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030 4009, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Novartis Investigative Site
Melbourne, Victoria, 3000, Australia
-
Novartis Investigative Site
Montreal, Quebec, H2W 1T8, Canada
-
Novartis Investigative Site
Villejuif, 94800, France
-
Novartis Investigative Site
Essen, 45147, Germany
-
Novartis Investigative Site
Milan, MI, 20133, Italy
-
Novartis Investigative Site
Rozzano, MI, 20089, Italy
-
Novartis Investigative Site
Chuo Ku, Tokyo, 104 0045, Japan
-
Novartis Investigative Site
Rotterdam, South Holland, 3015 GD, Netherlands
-
Novartis Investigative Site
Barcelona, Catalonia, 08035, Spain
-
Novartis Investigative Site
Zurich, 8091, Switzerland
-
Novartis Investigative Site
Manchester, M20 2BX, United Kingdom
-
Uni of Chi Medi Ctr Hema and Onco
Chicago, Illinois, 60637, United States
-
University of California LA
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.